Subclinical hypercortisolism: Debatable or visible on the lightbox?

Endocrine

Volumn 42, Issue 1, 2012, Pages 7-8

  Vassiliadi, Dimitra A ^a   Tsagarakis, Stylianos ^a  

^a EVANGELISMOS HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; HYDROCORTISONE;

ADRENAL CORTEX ADENOMA; ADRENAL INCIDENTALOMA; COMPUTER ASSISTED TOMOGRAPHY; CUSHING SYNDROME; DEXAMETHASONE SUPPRESSION TEST; EDITORIAL; HUMAN; HYDROCORTISONE RELEASE; HYPERCORTISOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SUBCLINICAL HYPERCORTISOLISM; TUMOR VOLUME;

EID: 84864967122     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-012-9689-9     Document Type: Editorial

References (10)

1. M. Letulle, Note sur la degenerescence graisseuse de la capsule surrenale. Bull. Mem. Soc. Anat. Paris 3, 264-267 (1889)
2. R.T. Kloos, M.D. Gross, I.R. Francis, M. Korobkin, B. Shapiro, Incidentally discovered adrenal masses. Endocr. Rev. 16, 460-484 (1995)
3. D.A. Vassiliadi, S. Tsagarakis, Endocrine incidentalomas-challenges imposed by incidentally discovered lesions. Nat. Rev. Endocrinol. 7, 668-680 (2011)
4. D.A. Vassiliadi, G. Ntali, E. Vicha, S. Tsagarakis, High prevalence of subclinical hypercortisolism in patients with bilateral adrenal incidentalomas: a challenge to management. Clin. Endocrinol. (Oxf) 74, 438-444 (2011)
5. S. Tsagarakis, D. Vassiliadi, N. Thalassinos, Endogenous subclinical hypercortisolism: Diagnostic uncertainties and clinical implications. J. Endocrinol. Invest. 29, 471-482 (2006)
6. T.J. Cawood, P.J. Hunt, D. O'Shea, D. Cole, S. Soule, Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant; time for a rethink? Eur. J. Endocrinol. 161, 513-527 (2009)
7. H. Olsen, E. Nordenstrom, A. Bergenfelz, U. Nyman, S. Valdemarsson, E. Palmqvist, Subclinical hypercortisolism and CT appearance in adrenal incidentalomas: a multicenter study from Southern Sweden. Endocrine (2012). doi:10.1007/s12020-012-9622-2
8. S. Tsagarakis, C. Roboti, P. Kokkoris, V. Vasiliou, C. Alevizaki, N. Thalassinos, Elevated post-dexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary adrenal axis in patients with adrenal incidentalomas. Clin. Endocrinol. (Oxf) 49, 165-171 (1998)
9. M. Terzolo, A. Pia, G. Reimondo, Subclinical Cushing's syndrome: definition and management. Clin. Endocrinol. (Oxf) 76, 12-18 (2012)
10. P.M. Stewart, Is subclinical Cushing's syndrome an entity or a statistical fallout from diagnostic testing? Consensus surrounding the diagnosis is required before optimal treatment can be defined. J. Clin. Endocrinol. Metab. 95, 2618-2620 (2010)